[Whitepaper] Understanding Precision Medicine in Oncology

In oncology, targeted therapies are demonstrating significant promise, but only in relatively limited settings…at least so far.  Nevertheless, accelerating pharmaceutical and diagnostic development has enormous potential to improve outcomes and save lives.  In this paper, we explore the challenges and potential of evolving and integrating precision medicine into oncology.  This paper consists of three parts:

  1. The Science Behind Molecular Testing – Overview of molecular alterations, testing methodologies, and sample sources
  2. Current Clinical Utility and Commercial Challenges – Discussion of how precision medicine is currently applied in oncology, as well as key challenges in advancing precision medicine
  3. Future Co-Evolution of Diagnostics and Pharma – A look ahead at the future market, as well as keys to success for pharmaceutical and diagnostics companies


Sponsored by: